Identification of Key Pathways and Hub Genes in Breast Cancer Via a Systems Biology Approach
Pharmaceutical Sciences · 30.04.2026 · 32 (2) · 309-323
DOI: 10.34172/ps.026.42698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences, online erschienen am 30.04.2026. Verfasst von Seyedeh Fatemeh Angoshtan und 3 weiteren Autor:innen. Die Arbeit nennt 145 Literaturangaben.
Abstract (Originalsprache)
Background
Breast cancer (BC) remains the leading cause of cancer-related mortality among women globally. Despite significant advances in diagnosis and treatment, the molecular mechanisms driving breast tumorigenesis are not yet fully elucidated. This study aimed to identify key genes and signaling pathways associated with BC pathogenesis and prognosis through comprehensive bioinformatic analysis.
Methods
In this study, gene expression data from the GSE124646 dataset were retrieved from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified based on the criteria of |log₂ fold change|>1.5 and P value
Zitieren
APA
Angoshtan, S. F., Mori, Z., Naeimi, S., & Aghdam, E. M. (2026). Identification of Key Pathways and Hub Genes in Breast Cancer Via a Systems Biology Approach. Pharmaceutical Sciences, 32(2), 309-323. https://doi.org/10.34172/ps.026.42698
Vancouver
Angoshtan SF, Mori Z, Naeimi S, Aghdam EM. Identification of Key Pathways and Hub Genes in Breast Cancer Via a Systems Biology Approach. Pharmaceutical Sciences. 2026;32(2):309-323. doi:10.34172/ps.026.42698
BibTeX
@article{Angoshtan2026,
author = {Angoshtan, Seyedeh Fatemeh and Mori, Zeinab and Naeimi, Saeideh and Aghdam, Elnaz Mehdizadeh},
title = {Identification of Key Pathways and Hub Genes in Breast Cancer Via a Systems Biology Approach},
journal = {Pharmaceutical Sciences},
year = {2026},
volume = {32},
number = {2},
pages = {309--323},
doi = {10.34172/ps.026.42698}
}
EUVIMED